Physician profile
Muhammad Kashlan
NPI 1346224078
$2,066.48
in general payments reported to CMS, 2019-2025
25 companies · $482 in 2025
The $482 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $109 · 2021: $65.10 · 2022: $214 · 2023: $401 · 2024: $604 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,471 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,470.86 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $492.50 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $216.53 | 2020-2025 | Airsupra, Fasenra, Breztri |
| Insmed, INC. | $177.88 | 2021-2025 | Arikayce |
| Ethicon INC. | $145.89 | 2023 | Monarch Platform |
| Sunovion Pharmaceuticals INC. | $121.10 | 2019-2020 | |
| United Therapeutics Corporation | $107.50 | 2022-2025 | Tyvaso, Tyvaso |
| Harmony Biosciences LLC | $97.32 | 2023-2024 | Wakix |
| Regeneron Healthcare Solutions, INC. | $91.18 | 2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.94 | 2023-2024 | Ofev |
| Intuitive Surgical, INC. | $63.30 | 2024 | |
| Jazz Pharmaceuticals INC. | $56.87 | 2022 | |
| Genzyme Corporation | $54.63 | 2025 | |
| Abbvie INC. | $54.16 | 2022-2023 | |
| Verona Pharma, INC. | $51.24 | 2025 | Ohtuvayre |
| Csl Behring | $45.88 | 2024 | Haegarda |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $44.31 | 2024 | |
| Baxter Healthcare | $25.81 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Electromed, INC. | $21.98 | 2025 | Smartvest |
| Avadel Cns Pharmaceuticals, LLC | $21.88 | 2024 | Lumryz |
| Janssen Pharmaceuticals, INC | $19.61 | 2020 | |
| Philips North America LLC | $18.02 | 2021 | |
| Covis Pharma Gmbh | $17.98 | 2022 | |
| Viatris Specialty LLC | $17.30 | 2025 | Yupelri |
| Mylan Specialty L.P. | $13.46 | 2021 | |
| Inogen, INC. | $9.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Kashlan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.